FDA gives tentative approval for generic HIV prevention shot by Dr Reddy
The U.S. Food and Drug Administration granted tentative approval to Dr Reddy's Laboratories to manufacture a generic version of an HIV prevention medicine.
Generic drug maker plans shipment
Dr Reddy's Laboratories intends to begin shipping the medication next month. This move aims to help dozens of low- and middle-income countries access the treatment quickly. The annual cost per person will be $40, which matches the price of daily tablets.
Lonza expands U.S. manufacturing footprint
Lonza agreed to purchase five U.S. manufacturing sites from Merck KGaA according to Reuters. This acquisition more than doubles Lonza's presence in the country and increases its total site count to nine. The deal allows Germany's Merck to focus more on drug development while Lonza expands capabilities for cancer and gene therapies.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.